GLP-1 Receptor Agonist · 5mg lyophilized powder · Lot VT-003
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist originally developed for type 2 diabetes and obesity research. It is one of the most in-demand research peptides available in Canada today, widely studied for its appetite-suppressive and metabolic effects.
VELTRIDE supplies Semaglutide 5mg for research use at ≥98% HPLC purity with a third-party COA included. All orders ship discreetly Canada-wide from Kelowna, BC, typically within 1 business day.
Semaglutide is frequently studied alongside AOD-9604 or HGH Frag 176-191 for comprehensive fat-loss research protocols. For stronger GLP-1 pathway research, Tirzepatide (dual GLP-1/GIP agonist) or Retatrutide (triple agonist) are also available from VELTRIDE.
🔒 STRIPE · DISCREET SHIPPING · CA ONLY
WHAT RESEARCHERS ARE SAYING
“Semaglutide from VELTRIDE has been consistent across 4 orders. COA is thorough, ships to Calgary in 2 days.”
— D.R. — Calgary, AB
“Tried another supplier first and noticed a big difference when I switched. Better research results, cleaner product.”
— S.K. — Vancouver, BC
“Easy ordering, discreet packaging, responsive team. Exactly what you want from a peptide supplier.”
— C.H. — Winnipeg, MB